AstraZeneca buying drug developer Alexion for $39 billion

AstraZeneca to buy Alexion Pharmaceuticals in $39 billion dealПодробнее

AstraZeneca shares dip after $39 bln Alexion dealПодробнее

LBLV AstraZeneca buys pharma Alexion for $39 billion 2020/14/12Подробнее

Sponsor Perspective: Alexion Pharmaceuticals | Rare Disease Day: 40 Years of the Orphan Drug ActПодробнее

Tom Defay, Deputy Head Diagnostics Strategy & Development, Alexion, AstraZeneca Rare Disease-BIO2022Подробнее

ASTRAZENECA (NASDAQ: AZN) TO ACQUIRE ALEXION (NASDAQ: ALXN) FOR $39 BILLION - CEO COMMENTARYПодробнее

AstraZeneca to Buy Alexion for $39 Billion in Cash and StockПодробнее

News #Shorts - AstraZeneca buying drug developer Alexion for $39 billionПодробнее

AstraZeneca Acquires Alexion for $39 Billion - Gabelli Funds Analyst Jing He (12.14.2020)Подробнее

Life At Alexion: Being Part of AstraZenecaПодробнее

Sponsor Perspective: Alexion Pharmaceuticals | Rare Disease Treatments: Regulatory & Policy ReformПодробнее

AstraZeneca CEO Soriot on Pharmaceuticals in ChinaПодробнее

AstraZeneca and U.S. strike deal to develop Covid-19 antibody drug supplyПодробнее

FILE-PFIZER WITHDRAWS OFFERS TO ASTRAZENECAПодробнее

Drugs giant Pfizer's move on AstraZeneca rebuffed - economyПодробнее

Ждать дивиденды от Аэрофлота и Ozon? Топ-3 идеи на рынке акций, перспективы Хэдхантера и АФК СистемаПодробнее

Alexion, AstraZeneca Rare Disease: Who We AreПодробнее

Stock to get your pseudo China trade on | The TradeПодробнее